 | • レポートコード：D005-07897 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、HER2抗体の世界市場を広く調査・分析し、今後の市場展望をまとめております。HER2抗体の種類別市場規模（トラスツズマブ、ラパチニブ、アドトラスツズマブエンタンシン、ペルツズマブ、エベロリムス）、用途別市場規模（病院、医療センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Genentech Inc、Bio-Techne、Abnova Corporation、Novartis AG、Biocon Limited、Pfizer、Celltrion、InvivoGen ・地域別グローバル市場分析 2015年-2020年 ・HER2抗体の北米市場（アメリカ、カナダ、メキシコ） ・HER2抗体のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・HER2抗体のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・HER2抗体の南米市場（ブラジル、アルゼンチン） ・HER2抗体の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：トラスツズマブ、ラパチニブ、アドトラスツズマブエンタンシン、ペルツズマブ、エベロリムス ・用途別分析：病院、医療センター ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global HER2 Antibody market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The HER2 Antibody market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
HER2 Antibody market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, HER2 Antibody market has been segmented into
Trastuzumab
Lapatinib
Ado-trastuzumab Emtansine
Pertuzumab
Everolimus
By Application, HER2 Antibody has been segmented into:
Hospital
Medical Center
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global HER2 Antibody market presented in the report. This section sheds light on the sales growth of different regional and country-level HER2 Antibody markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global HER2 Antibody market.
The report offers in-depth assessment of the growth and other aspects of the HER2 Antibody market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and HER2 Antibody Market Share Analysis
HER2 Antibody competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, HER2 Antibody sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the HER2 Antibody sales, revenue and market share for each player covered in this report.
The major players covered in HER2 Antibody are:
Genentech Inc
Bio-Techne
Abnova Corporation
Novartis AG
Biocon Limited
Pfizer
Celltrion
InvivoGen
Among other players domestic and global, HER2 Antibody market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe HER2 Antibody product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of HER2 Antibody, with price, sales, revenue and global market share of HER2 Antibody in 2018 and 2019.
Chapter 3, the HER2 Antibody competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HER2 Antibody breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, HER2 Antibody market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe HER2 Antibody sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 HER2 Antibody Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global HER2 Antibody Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Trastuzumab
1.2.3 Lapatinib
1.2.4 Ado-trastuzumab Emtansine
1.2.5 Pertuzumab
1.2.6 Everolimus
1.3 Market Analysis by Application
1.3.1 Overview: Global HER2 Antibody Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Medical Center
1.4 Overview of Global HER2 Antibody Market
1.4.1 Global HER2 Antibody Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Genentech Inc
2.1.1 Genentech Inc Details
2.1.2 Genentech Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Genentech Inc SWOT Analysis
2.1.4 Genentech Inc Product and Services
2.1.5 Genentech Inc HER2 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bio-Techne
2.2.1 Bio-Techne Details
2.2.2 Bio-Techne Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bio-Techne SWOT Analysis
2.2.4 Bio-Techne Product and Services
2.2.5 Bio-Techne HER2 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Abnova Corporation
2.3.1 Abnova Corporation Details
2.3.2 Abnova Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Abnova Corporation SWOT Analysis
2.3.4 Abnova Corporation Product and Services
2.3.5 Abnova Corporation HER2 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis AG SWOT Analysis
2.4.4 Novartis AG Product and Services
2.4.5 Novartis AG HER2 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Biocon Limited
2.5.1 Biocon Limited Details
2.5.2 Biocon Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Biocon Limited SWOT Analysis
2.5.4 Biocon Limited Product and Services
2.5.5 Biocon Limited HER2 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer HER2 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Celltrion
2.7.1 Celltrion Details
2.7.2 Celltrion Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Celltrion SWOT Analysis
2.7.4 Celltrion Product and Services
2.7.5 Celltrion HER2 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 InvivoGen
2.8.1 InvivoGen Details
2.8.2 InvivoGen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 InvivoGen SWOT Analysis
2.8.4 InvivoGen Product and Services
2.8.5 InvivoGen HER2 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global HER2 Antibody Sales and Market Share by Manufacturer (2018-2019)
3.2 Global HER2 Antibody Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 HER2 Antibody Manufacturer Market Share in 2019
3.3.2 Top 6 HER2 Antibody Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global HER2 Antibody Sales, Revenue and Market Share by Regions
4.1.1 Global HER2 Antibody Sales and Market Share by Regions (2015-2020)
4.1.2 Global HER2 Antibody Revenue and Market Share by Regions (2015-2020)
4.2 North America HER2 Antibody Sales and Growth Rate (2015-2020)
4.3 Europe HER2 Antibody Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific HER2 Antibody Sales and Growth Rate (2015-2020)
4.5 South America HER2 Antibody Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa HER2 Antibody Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America HER2 Antibody Sales, Revenue and Market Share by Country
5.1.1 North America HER2 Antibody Sales and Market Share by Country (2015-2020)
5.1.2 North America HER2 Antibody Revenue and Market Share by Country (2015-2020)
5.2 United States HER2 Antibody Sales and Growth Rate (2015-2020)
5.3 Canada HER2 Antibody Sales and Growth Rate (2015-2020)
5.4 Mexico HER2 Antibody Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe HER2 Antibody Sales, Revenue and Market Share by Country
6.1.1 Europe HER2 Antibody Sales and Market Share by Country (2015-2020)
6.1.2 Europe HER2 Antibody Revenue and Market Share by Country (2015-2020)
6.2 Germany HER2 Antibody Sales and Growth Rate (2015-2020)
6.3 UK HER2 Antibody Sales and Growth Rate (2015-2020)
6.4 France HER2 Antibody Sales and Growth Rate (2015-2020)
6.5 Russia HER2 Antibody Sales and Growth Rate (2015-2020)
6.6 Italy HER2 Antibody Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific HER2 Antibody Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific HER2 Antibody Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific HER2 Antibody Revenue and Market Share by Regions (2015-2020)
7.2 China HER2 Antibody Sales and Growth Rate (2015-2020)
7.3 Japan HER2 Antibody Sales and Growth Rate (2015-2020)
7.4 Korea HER2 Antibody Sales and Growth Rate (2015-2020)
7.5 India HER2 Antibody Sales and Growth Rate (2015-2020)
7.6 Southeast Asia HER2 Antibody Sales and Growth Rate (2015-2020)
7.7 Australia HER2 Antibody Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America HER2 Antibody Sales, Revenue and Market Share by Country
8.1.1 South America HER2 Antibody Sales and Market Share by Country (2015-2020)
8.1.2 South America HER2 Antibody Revenue and Market Share by Country (2015-2020)
8.2 Brazil HER2 Antibody Sales and Growth Rate (2015-2020)
8.3 Argentina HER2 Antibody Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa HER2 Antibody Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa HER2 Antibody Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa HER2 Antibody Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia HER2 Antibody Sales and Growth Rate (2015-2020)
9.3 Turkey HER2 Antibody Sales and Growth Rate (2015-2020)
9.4 Egypt HER2 Antibody Sales and Growth Rate (2015-2020)
9.5 South Africa HER2 Antibody Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global HER2 Antibody Sales and Market Share by Type (2015-2020)
10.2 Global HER2 Antibody Revenue and Market Share by Type (2015-2020)
10.3 Global HER2 Antibody Price by Type (2015-2020)
11 Global HER2 Antibody Market Segment by Application
11.1 Global HER2 Antibody Sales Market Share by Application (2015-2020)
11.2 Global HER2 Antibody Revenue Market Share by Application (2015-2020)
11.3 Global HER2 Antibody Price by Application (2015-2020)
12 Market Forecast
12.1 Global HER2 Antibody Sales, Revenue and Growth Rate (2021-2025)
12.2 HER2 Antibody Market Forecast by Regions (2021-2025)
12.2.1 North America HER2 Antibody Market Forecast (2021-2025)
12.2.2 Europe HER2 Antibody Market Forecast (2021-2025)
12.2.3 Asia-Pacific HER2 Antibody Market Forecast (2021-2025)
12.2.4 South America HER2 Antibody Market Forecast (2021-2025)
12.2.5 Middle East & Africa HER2 Antibody Market Forecast (2021-2025)
12.3 HER2 Antibody Market Forecast by Type (2021-2025)
12.3.1 Global HER2 Antibody Sales Forecast by Type (2021-2025)
12.3.2 Global HER2 Antibody Market Share Forecast by Type (2021-2025)
12.4 HER2 Antibody Market Forecast by Application (2021-2025)
12.4.1 Global HER2 Antibody Sales Forecast by Application (2021-2025)
12.4.2 Global HER2 Antibody Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global HER2 Antibody Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of HER2 Antibody by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global HER2 Antibody Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Genentech Inc Basic Information, Manufacturing Base and Competitors
Table 8. Genentech Inc HER2 Antibody Major Business
Table 9. Genentech Inc HER2 Antibody Total Revenue (USD Million) (2018-2019)
Table 10. Genentech Inc SWOT Analysis
Table 11. Genentech Inc HER2 Antibody Product and Services
Table 12. Genentech Inc HER2 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 14. Bio-Techne HER2 Antibody Major Business
Table 15. Bio-Techne HER2 Antibody Total Revenue (USD Million) (2018-2019)
Table 16. Bio-Techne SWOT Analysis
Table 17. Bio-Techne HER2 Antibody Product and Services
Table 18. Bio-Techne HER2 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Abnova Corporation Basic Information, Manufacturing Base and Competitors
Table 20. Abnova Corporation HER2 Antibody Major Business
Table 21. Abnova Corporation HER2 Antibody Total Revenue (USD Million) (2018-2019)
Table 22. Abnova Corporation SWOT Analysis
Table 23. Abnova Corporation HER2 Antibody Product and Services
Table 24. Abnova Corporation HER2 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 26. Novartis AG HER2 Antibody Major Business
Table 27. Novartis AG HER2 Antibody Total Revenue (USD Million) (2018-2019)
Table 28. Novartis AG SWOT Analysis
Table 29. Novartis AG HER2 Antibody Product and Services
Table 30. Novartis AG HER2 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Biocon Limited Basic Information, Manufacturing Base and Competitors
Table 32. Biocon Limited HER2 Antibody Major Business
Table 33. Biocon Limited HER2 Antibody Total Revenue (USD Million) (2018-2019)
Table 34. Biocon Limited SWOT Analysis
Table 35. Biocon Limited HER2 Antibody Product and Services
Table 36. Biocon Limited HER2 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Pfizer Basic Information, Manufacturing Base and Competitors
Table 38. Pfizer HER2 Antibody Major Business
Table 39. Pfizer HER2 Antibody Total Revenue (USD Million) (2018-2019)
Table 40. Pfizer SWOT Analysis
Table 41. Pfizer HER2 Antibody Product and Services
Table 42. Pfizer HER2 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Celltrion Basic Information, Manufacturing Base and Competitors
Table 44. Celltrion HER2 Antibody Major Business
Table 45. Celltrion HER2 Antibody Total Revenue (USD Million) (2018-2019)
Table 46. Celltrion SWOT Analysis
Table 47. Celltrion HER2 Antibody Product and Services
Table 48. Celltrion HER2 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. InvivoGen Basic Information, Manufacturing Base and Competitors
Table 50. InvivoGen HER2 Antibody Major Business
Table 51. InvivoGen HER2 Antibody Total Revenue (USD Million) (2018-2019)
Table 52. InvivoGen SWOT Analysis
Table 53. InvivoGen HER2 Antibody Product and Services
Table 54. InvivoGen HER2 Antibody Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global HER2 Antibody Sales by Manufacturer (2018-2019) (K MT)
Table 56. Global HER2 Antibody Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global HER2 Antibody Sales by Regions (2015-2020) (K MT)
Table 58. Global HER2 Antibody Sales Market Share by Regions (2015-2020)
Table 59. Global HER2 Antibody Revenue by Regions (2015-2020) (USD Million)
Table 60. North America HER2 Antibody Sales by Countries (2015-2020) (K MT)
Table 61. North America HER2 Antibody Sales Market Share by Countries (2015-2020)
Table 62. North America HER2 Antibody Revenue by Countries (2015-2020) (USD Million)
Table 63. North America HER2 Antibody Revenue Market Share by Countries (2015-2020)
Table 64. Europe HER2 Antibody Sales by Countries (2015-2020) (K MT)
Table 65. Europe HER2 Antibody Sales Market Share by Countries (2015-2020)
Table 66. Europe HER2 Antibody Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific HER2 Antibody Sales by Regions (2015-2020) (K MT)
Table 68. Asia-Pacific HER2 Antibody Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific HER2 Antibody Revenue by Regions (2015-2020) (USD Million)
Table 70. South America HER2 Antibody Sales by Countries (2015-2020) (K MT)
Table 71. South America HER2 Antibody Sales Market Share by Countries (2015-2020)
Table 72. South America HER2 Antibody Revenue by Countries (2015-2020) (USD Million)
Table 73. South America HER2 Antibody Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa HER2 Antibody Sales by Countries (2015-2020) (K MT)
Table 75. Middle East & Africa HER2 Antibody Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa HER2 Antibody Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa HER2 Antibody Revenue Market Share by Countries (2015-2020)
Table 78. Global HER2 Antibody Sales by Type (2015-2020) (K MT)
Table 79. Global HER2 Antibody Sales Share by Type (2015-2020)
Table 80. Global HER2 Antibody Revenue by Type (2015-2020) (USD Million)
Table 81. Global HER2 Antibody Revenue Share by Type (2015-2020)
Table 82. Global HER2 Antibody Sales by Application (2015-2020) (K MT)
Table 83. Global HER2 Antibody Sales Share by Application (2015-2020)
Table 84. Global HER2 Antibody Sales Forecast by Regions (2021-2025) (K MT)
Table 85. Global HER2 Antibody Market Share Forecast by Regions (2021-2025)
Table 86. Global HER2 Antibody Sales Forecast by Type (2021-2025) (K MT)
Table 87. Global HER2 Antibody Market Share Forecast by Type (2021-2025)
Table 88. Global HER2 Antibody Sales Forecast by Application (2021-2025)
Table 89. Global HER2 Antibody Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. HER2 Antibody Picture
Figure 2. Global Sales Market Share of HER2 Antibody by Type in 2019
Figure 3. Trastuzumab Picture
Figure 4. Lapatinib Picture
Figure 5. Ado-trastuzumab Emtansine Picture
Figure 6. Pertuzumab Picture
Figure 7. Everolimus Picture
Figure 8. HER2 Antibody Sales Market Share by Application in 2018
Figure 9. Hospital Picture
Figure 10. Medical Center Picture
Figure 11. Global HER2 Antibody Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States HER2 Antibody Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada HER2 Antibody Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico HER2 Antibody Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany HER2 Antibody Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France HER2 Antibody Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK HER2 Antibody Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia HER2 Antibody Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy HER2 Antibody Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China HER2 Antibody Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan HER2 Antibody Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea HER2 Antibody Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India HER2 Antibody Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia HER2 Antibody Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia HER2 Antibody Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil HER2 Antibody Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt HER2 Antibody Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia HER2 Antibody Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa HER2 Antibody Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey HER2 Antibody Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global HER2 Antibody Sales Market Share by Manufacturer in 2019
Figure 32. Global HER2 Antibody Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 HER2 Antibody Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 HER2 Antibody Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 37. Global HER2 Antibody Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global HER2 Antibody Revenue Market Share by Regions (2015-2020)
Figure 39. Global HER2 Antibody Revenue Market Share by Regions in 2018
Figure 40. North America HER2 Antibody Sales and Growth Rate (2015-2020)
Figure 41. Europe HER2 Antibody Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific HER2 Antibody Sales and Growth Rate (2015-2020)
Figure 43. South America HER2 Antibody Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa HER2 Antibody Sales and Growth Rate (2015-2020)
Figure 45. North America HER2 Antibody Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America HER2 Antibody Sales Market Share by Countries (2015-2020)
Figure 47. North America HER2 Antibody Sales Market Share by Countries in 2018
Figure 48. North America HER2 Antibody Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America HER2 Antibody Revenue Market Share by Countries in 2018
Figure 50. United States HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Canada HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Mexico HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Europe HER2 Antibody Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe HER2 Antibody Revenue Market Share by Countries (2015-2020)
Figure 55. Europe HER2 Antibody Revenue Market Share by Countries in 2019
Figure 56. Germany HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 57. UK HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 58. France HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Russia HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Italy HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Asia-Pacific HER2 Antibody Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific HER2 Antibody Sales Market Share by Regions 2019
Figure 63. Asia-Pacific HER2 Antibody Revenue Market Share by Regions 2019
Figure 64. China HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Japan HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Korea HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 67. India HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Southeast Asia HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 69. South America HER2 Antibody Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America HER2 Antibody Sales Market Share by Countries in 2019
Figure 71. South America HER2 Antibody Revenue Market Share by Countries in 2019
Figure 72. Brazil HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Argentina HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Middle East and Africa HER2 Antibody Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa HER2 Antibody Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa HER2 Antibody Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa HER2 Antibody Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Egypt HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Turkey HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 81. South Africa HER2 Antibody Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Global HER2 Antibody Sales and Growth Rate (2021-2025) (K MT)
Figure 83. Global HER2 Antibody Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales HER2 Antibody Market Forecast (2021-2025) (K MT)
Figure 85. Europe Sales HER2 Antibody Market Forecast (2021-2025) (K MT)
Figure 86. Asia-Pacific Sales HER2 Antibody Market Forecast (2021-2025) (K MT)
Figure 87. South America Sales HER2 Antibody Market Forecast (2021-2025) (K MT)
Figure 88. Middle East & Africa Sales HER2 Antibody Market Forecast (2021-2025) (K MT)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
キメラ抗体の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Chimeric Antibody market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Chimeric Antibody market re…- 抗体生産の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Antibody Production market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.7% in the forecast period of 2020 to 2025 and will expected to reach USD 11300 million by 2025, from USD 8727.5 million in 2019. The Antibody Producti…
- トラスツズマブの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Trastuzumab market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Trastuzumab market report provide…
- ペルツズマブの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pertuzumab market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pertuzumab market report provides …
- エベロリムス錠の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Everolimus Tablet market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Everolimus Tablet market re…